Industry Research Reports
Home > Reports > Service & Software > Global Pharmaceutical Cold Chain Management Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pharmaceutical Cold Chain Management Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-10-23
Pages: 148 Pages
Report ld: 5218655
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Pharmaceutical Cold Chain Management market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pharmaceutical Cold Chain Management market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Aeris Group
- American Aerogel Corporation
- Cold Chain Technologies
- Cryopak
- CSafe
- DS Smith Pharma
- EcoCool GmbH
- Envirotainer
- Intelsius
- Pelican Biothermal
- Skycell
- Sofrigam SA Ltd.
- Softbox Systems
- Sonoco Products Company
- Va-Q-tec AG
- World Courier
- ThemoFisher
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Self Management
- Self Operated + Outsourcing
- Outsourcing Three Parties
Segment by Application
- Temperature-Sensitive Pharmaceuticals
- Vaccines
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Pharmaceutical Cold Chain Management study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharmaceutical Cold Chain Management: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Cold Chain Management Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Self Management
1.2.3 Self Operated + Outsourcing
1.2.4 Outsourcing Three Parties
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Cold Chain Management Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Temperature-Sensitive Pharmaceuticals
1.3.3 Vaccines
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Cold Chain Management Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Cold Chain Management Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmaceutical Cold Chain Management Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmaceutical Cold Chain Management Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Self Management Market Size by Players
3.3.2 Self Operated + Outsourcing Market Size by Players
3.3.3 Outsourcing Three Parties Market Size by Players
3.4 Global Pharmaceutical Cold Chain Management Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Cold Chain Management Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Cold Chain Management Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmaceutical Cold Chain Management Market Size by Type (2020-2031)
6.4 North America Pharmaceutical Cold Chain Management Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Cold Chain Management Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmaceutical Cold Chain Management Market Size by Type (2020-2031)
7.4 Europe Pharmaceutical Cold Chain Management Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Cold Chain Management Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Cold Chain Management Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Cold Chain Management Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmaceutical Cold Chain Management Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmaceutical Cold Chain Management Market Size by Type (2020-2031)
9.4 Central and South America Pharmaceutical Cold Chain Management Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Cold Chain Management Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Cold Chain Management Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Cold Chain Management Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Cold Chain Management Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Aeris Group
11.1.1 Aeris Group Corporation Information
11.1.2 Aeris Group Business Overview
11.1.3 Aeris Group Pharmaceutical Cold Chain Management Product Features and Attributes
11.1.4 Aeris Group Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.1.5 Aeris Group Pharmaceutical Cold Chain Management Revenue by Product in 2024
11.1.6 Aeris Group Pharmaceutical Cold Chain Management Revenue by Application in 2024
11.1.7 Aeris Group Pharmaceutical Cold Chain Management Revenue by Geographic Area in 2024
11.1.8 Aeris Group Pharmaceutical Cold Chain Management SWOT Analysis
11.1.9 Aeris Group Recent Developments
11.2 American Aerogel Corporation
11.2.1 American Aerogel Corporation Corporation Information
11.2.2 American Aerogel Corporation Business Overview
11.2.3 American Aerogel Corporation Pharmaceutical Cold Chain Management Product Features and Attributes
11.2.4 American Aerogel Corporation Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.2.5 American Aerogel Corporation Pharmaceutical Cold Chain Management Revenue by Product in 2024
11.2.6 American Aerogel Corporation Pharmaceutical Cold Chain Management Revenue by Application in 2024
11.2.7 American Aerogel Corporation Pharmaceutical Cold Chain Management Revenue by Geographic Area in 2024
11.2.8 American Aerogel Corporation Pharmaceutical Cold Chain Management SWOT Analysis
11.2.9 American Aerogel Corporation Recent Developments
11.3 Cold Chain Technologies
11.3.1 Cold Chain Technologies Corporation Information
11.3.2 Cold Chain Technologies Business Overview
11.3.3 Cold Chain Technologies Pharmaceutical Cold Chain Management Product Features and Attributes
11.3.4 Cold Chain Technologies Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.3.5 Cold Chain Technologies Pharmaceutical Cold Chain Management Revenue by Product in 2024
11.3.6 Cold Chain Technologies Pharmaceutical Cold Chain Management Revenue by Application in 2024
11.3.7 Cold Chain Technologies Pharmaceutical Cold Chain Management Revenue by Geographic Area in 2024
11.3.8 Cold Chain Technologies Pharmaceutical Cold Chain Management SWOT Analysis
11.3.9 Cold Chain Technologies Recent Developments
11.4 Cryopak
11.4.1 Cryopak Corporation Information
11.4.2 Cryopak Business Overview
11.4.3 Cryopak Pharmaceutical Cold Chain Management Product Features and Attributes
11.4.4 Cryopak Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.4.5 Cryopak Pharmaceutical Cold Chain Management Revenue by Product in 2024
11.4.6 Cryopak Pharmaceutical Cold Chain Management Revenue by Application in 2024
11.4.7 Cryopak Pharmaceutical Cold Chain Management Revenue by Geographic Area in 2024
11.4.8 Cryopak Pharmaceutical Cold Chain Management SWOT Analysis
11.4.9 Cryopak Recent Developments
11.5 CSafe
11.5.1 CSafe Corporation Information
11.5.2 CSafe Business Overview
11.5.3 CSafe Pharmaceutical Cold Chain Management Product Features and Attributes
11.5.4 CSafe Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.5.5 CSafe Pharmaceutical Cold Chain Management Revenue by Product in 2024
11.5.6 CSafe Pharmaceutical Cold Chain Management Revenue by Application in 2024
11.5.7 CSafe Pharmaceutical Cold Chain Management Revenue by Geographic Area in 2024
11.5.8 CSafe Pharmaceutical Cold Chain Management SWOT Analysis
11.5.9 CSafe Recent Developments
11.6 DS Smith Pharma
11.6.1 DS Smith Pharma Corporation Information
11.6.2 DS Smith Pharma Business Overview
11.6.3 DS Smith Pharma Pharmaceutical Cold Chain Management Product Features and Attributes
11.6.4 DS Smith Pharma Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.6.5 DS Smith Pharma Recent Developments
11.7 EcoCool GmbH
11.7.1 EcoCool GmbH Corporation Information
11.7.2 EcoCool GmbH Business Overview
11.7.3 EcoCool GmbH Pharmaceutical Cold Chain Management Product Features and Attributes
11.7.4 EcoCool GmbH Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.7.5 EcoCool GmbH Recent Developments
11.8 Envirotainer
11.8.1 Envirotainer Corporation Information
11.8.2 Envirotainer Business Overview
11.8.3 Envirotainer Pharmaceutical Cold Chain Management Product Features and Attributes
11.8.4 Envirotainer Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.8.5 Envirotainer Recent Developments
11.9 Intelsius
11.9.1 Intelsius Corporation Information
11.9.2 Intelsius Business Overview
11.9.3 Intelsius Pharmaceutical Cold Chain Management Product Features and Attributes
11.9.4 Intelsius Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.9.5 Intelsius Recent Developments
11.10 Pelican Biothermal
11.10.1 Pelican Biothermal Corporation Information
11.10.2 Pelican Biothermal Business Overview
11.10.3 Pelican Biothermal Pharmaceutical Cold Chain Management Product Features and Attributes
11.10.4 Pelican Biothermal Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Skycell
11.11.1 Skycell Corporation Information
11.11.2 Skycell Business Overview
11.11.3 Skycell Pharmaceutical Cold Chain Management Product Features and Attributes
11.11.4 Skycell Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.11.5 Skycell Recent Developments
11.12 Sofrigam SA Ltd.
11.12.1 Sofrigam SA Ltd. Corporation Information
11.12.2 Sofrigam SA Ltd. Business Overview
11.12.3 Sofrigam SA Ltd. Pharmaceutical Cold Chain Management Product Features and Attributes
11.12.4 Sofrigam SA Ltd. Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.12.5 Sofrigam SA Ltd. Recent Developments
11.13 Softbox Systems
11.13.1 Softbox Systems Corporation Information
11.13.2 Softbox Systems Business Overview
11.13.3 Softbox Systems Pharmaceutical Cold Chain Management Product Features and Attributes
11.13.4 Softbox Systems Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.13.5 Softbox Systems Recent Developments
11.14 Sonoco Products Company
11.14.1 Sonoco Products Company Corporation Information
11.14.2 Sonoco Products Company Business Overview
11.14.3 Sonoco Products Company Pharmaceutical Cold Chain Management Product Features and Attributes
11.14.4 Sonoco Products Company Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.14.5 Sonoco Products Company Recent Developments
11.15 Va-Q-tec AG
11.15.1 Va-Q-tec AG Corporation Information
11.15.2 Va-Q-tec AG Business Overview
11.15.3 Va-Q-tec AG Pharmaceutical Cold Chain Management Product Features and Attributes
11.15.4 Va-Q-tec AG Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.15.5 Va-Q-tec AG Recent Developments
11.16 World Courier
11.16.1 World Courier Corporation Information
11.16.2 World Courier Business Overview
11.16.3 World Courier Pharmaceutical Cold Chain Management Product Features and Attributes
11.16.4 World Courier Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.16.5 World Courier Recent Developments
11.17 ThemoFisher
11.17.1 ThemoFisher Corporation Information
11.17.2 ThemoFisher Business Overview
11.17.3 ThemoFisher Pharmaceutical Cold Chain Management Product Features and Attributes
11.17.4 ThemoFisher Pharmaceutical Cold Chain Management Revenue and Gross Margin (2020-2025)
11.17.5 ThemoFisher Recent Developments
12 Pharmaceutical Cold Chain ManagementIndustry Chain Analysis
12.1 Pharmaceutical Cold Chain Management Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Cold Chain Management Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Cold Chain Management Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Cold Chain Management Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Cold Chain Management Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Cold Chain Management Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Cold Chain Management Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Cold Chain Management Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pharmaceutical Cold Chain Management Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical Cold Chain Management Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pharmaceutical Cold Chain Management by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Cold Chain Management as of 2024)
Table 11. Global Pharmaceutical Cold Chain Management Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pharmaceutical Cold Chain Management Companies Headquarters
Table 13. Global Pharmaceutical Cold Chain Management Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pharmaceutical Cold Chain Management Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pharmaceutical Cold Chain Management Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pharmaceutical Cold Chain Management Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pharmaceutical Cold Chain Management Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pharmaceutical Cold Chain Management High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pharmaceutical Cold Chain Management Growth Accelerators and Market Barriers
Table 25. North America Pharmaceutical Cold Chain Management Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pharmaceutical Cold Chain Management Growth Accelerators and Market Barriers
Table 27. Europe Pharmaceutical Cold Chain Management Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pharmaceutical Cold Chain Management Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pharmaceutical Cold Chain Management Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pharmaceutical Cold Chain Management Investment Opportunities and Key Challenges
Table 31. Central and South America Pharmaceutical Cold Chain Management Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pharmaceutical Cold Chain Management Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pharmaceutical Cold Chain Management Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Aeris Group Corporation Information
Table 35. Aeris Group Description and Major Businesses
Table 36. Aeris Group Product Features and Attributes
Table 37. Aeris Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Aeris Group Revenue Proportion by Product in 2024
Table 39. Aeris Group Revenue Proportion by Application in 2024
Table 40. Aeris Group Revenue Proportion by Geographic Area in 2024
Table 41. Aeris Group Pharmaceutical Cold Chain Management SWOT Analysis
Table 42. Aeris Group Recent Developments
Table 43. American Aerogel Corporation Corporation Information
Table 44. American Aerogel Corporation Description and Major Businesses
Table 45. American Aerogel Corporation Product Features and Attributes
Table 46. American Aerogel Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. American Aerogel Corporation Revenue Proportion by Product in 2024
Table 48. American Aerogel Corporation Revenue Proportion by Application in 2024
Table 49. American Aerogel Corporation Revenue Proportion by Geographic Area in 2024
Table 50. American Aerogel Corporation Pharmaceutical Cold Chain Management SWOT Analysis
Table 51. American Aerogel Corporation Recent Developments
Table 52. Cold Chain Technologies Corporation Information
Table 53. Cold Chain Technologies Description and Major Businesses
Table 54. Cold Chain Technologies Product Features and Attributes
Table 55. Cold Chain Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Cold Chain Technologies Revenue Proportion by Product in 2024
Table 57. Cold Chain Technologies Revenue Proportion by Application in 2024
Table 58. Cold Chain Technologies Revenue Proportion by Geographic Area in 2024
Table 59. Cold Chain Technologies Pharmaceutical Cold Chain Management SWOT Analysis
Table 60. Cold Chain Technologies Recent Developments
Table 61. Cryopak Corporation Information
Table 62. Cryopak Description and Major Businesses
Table 63. Cryopak Product Features and Attributes
Table 64. Cryopak Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Cryopak Revenue Proportion by Product in 2024
Table 66. Cryopak Revenue Proportion by Application in 2024
Table 67. Cryopak Revenue Proportion by Geographic Area in 2024
Table 68. Cryopak Pharmaceutical Cold Chain Management SWOT Analysis
Table 69. Cryopak Recent Developments
Table 70. CSafe Corporation Information
Table 71. CSafe Description and Major Businesses
Table 72. CSafe Product Features and Attributes
Table 73. CSafe Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. CSafe Revenue Proportion by Product in 2024
Table 75. CSafe Revenue Proportion by Application in 2024
Table 76. CSafe Revenue Proportion by Geographic Area in 2024
Table 77. CSafe Pharmaceutical Cold Chain Management SWOT Analysis
Table 78. CSafe Recent Developments
Table 79. DS Smith Pharma Corporation Information
Table 80. DS Smith Pharma Description and Major Businesses
Table 81. DS Smith Pharma Product Features and Attributes
Table 82. DS Smith Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. DS Smith Pharma Recent Developments
Table 84. EcoCool GmbH Corporation Information
Table 85. EcoCool GmbH Description and Major Businesses
Table 86. EcoCool GmbH Product Features and Attributes
Table 87. EcoCool GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. EcoCool GmbH Recent Developments
Table 89. Envirotainer Corporation Information
Table 90. Envirotainer Description and Major Businesses
Table 91. Envirotainer Product Features and Attributes
Table 92. Envirotainer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Envirotainer Recent Developments
Table 94. Intelsius Corporation Information
Table 95. Intelsius Description and Major Businesses
Table 96. Intelsius Product Features and Attributes
Table 97. Intelsius Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Intelsius Recent Developments
Table 99. Pelican Biothermal Corporation Information
Table 100. Pelican Biothermal Description and Major Businesses
Table 101. Pelican Biothermal Product Features and Attributes
Table 102. Pelican Biothermal Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Pelican Biothermal Recent Developments
Table 104. Skycell Corporation Information
Table 105. Skycell Description and Major Businesses
Table 106. Skycell Product Features and Attributes
Table 107. Skycell Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Skycell Recent Developments
Table 109. Sofrigam SA Ltd. Corporation Information
Table 110. Sofrigam SA Ltd. Description and Major Businesses
Table 111. Sofrigam SA Ltd. Product Features and Attributes
Table 112. Sofrigam SA Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Sofrigam SA Ltd. Recent Developments
Table 114. Softbox Systems Corporation Information
Table 115. Softbox Systems Description and Major Businesses
Table 116. Softbox Systems Product Features and Attributes
Table 117. Softbox Systems Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Softbox Systems Recent Developments
Table 119. Sonoco Products Company Corporation Information
Table 120. Sonoco Products Company Description and Major Businesses
Table 121. Sonoco Products Company Product Features and Attributes
Table 122. Sonoco Products Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Sonoco Products Company Recent Developments
Table 124. Va-Q-tec AG Corporation Information
Table 125. Va-Q-tec AG Description and Major Businesses
Table 126. Va-Q-tec AG Product Features and Attributes
Table 127. Va-Q-tec AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Va-Q-tec AG Recent Developments
Table 129. World Courier Corporation Information
Table 130. World Courier Description and Major Businesses
Table 131. World Courier Product Features and Attributes
Table 132. World Courier Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. World Courier Recent Developments
Table 134. ThemoFisher Corporation Information
Table 135. ThemoFisher Description and Major Businesses
Table 136. ThemoFisher Product Features and Attributes
Table 137. ThemoFisher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. ThemoFisher Recent Developments
Table 139. Raw Materials Key Suppliers
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Cold Chain Management Product Picture
Figure 2. Global Pharmaceutical Cold Chain Management Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Self Management Product Picture
Figure 4. Self Operated + Outsourcing Product Picture
Figure 5. Outsourcing Three Parties Product Picture
Figure 6. Global Pharmaceutical Cold Chain Management Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Temperature-Sensitive Pharmaceuticals
Figure 8. Vaccines
Figure 9. Others
Figure 10. Pharmaceutical Cold Chain Management Report Years Considered
Figure 11. Global Pharmaceutical Cold Chain Management Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 13. Global Pharmaceutical Cold Chain Management Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Pharmaceutical Cold Chain Management Revenue Market Share by Region (2020-2031)
Figure 15. Global Pharmaceutical Cold Chain Management Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Self Management Revenue Market Share by Player in 2024
Figure 18. Self Operated + Outsourcing Revenue Market Share by Player in 2024
Figure 19. Outsourcing Three Parties Revenue Market Share by Player in 2024
Figure 20. Global Pharmaceutical Cold Chain Management Revenue Market Share by Type (2020-2031)
Figure 21. Global Pharmaceutical Cold Chain Management Revenue Market Share by Application (2020-2031)
Figure 22. North America Pharmaceutical Cold Chain Management Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Pharmaceutical Cold Chain Management Revenue (US$ Million) in 2024
Figure 24. North America Pharmaceutical Cold Chain Management Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Pharmaceutical Cold Chain Management Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Pharmaceutical Cold Chain Management Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Pharmaceutical Cold Chain Management Revenue (US$ Million) in 2024
Figure 31. Europe Pharmaceutical Cold Chain Management Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Pharmaceutical Cold Chain Management Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 34. France Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Pharmaceutical Cold Chain Management Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Pharmaceutical Cold Chain Management Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Pharmaceutical Cold Chain Management Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Pharmaceutical Cold Chain Management Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 46. India Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Pharmaceutical Cold Chain Management Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Pharmaceutical Cold Chain Management Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Pharmaceutical Cold Chain Management Revenue (US$ Million) in 2024
Figure 54. Central and South America Pharmaceutical Cold Chain Management Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Pharmaceutical Cold Chain Management Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Pharmaceutical Cold Chain Management Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Pharmaceutical Cold Chain Management Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Pharmaceutical Cold Chain Management Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Pharmaceutical Cold Chain Management Revenue (US$ Million) in 2024
Figure 60. South America Pharmaceutical Cold Chain Management Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Pharmaceutical Cold Chain Management Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Pharmaceutical Cold Chain Management Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Pharmaceutical Cold Chain Management Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Pharmaceutical Cold Chain Management Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Pharmaceutical Cold Chain Management Revenue (2020-2025) & (US$ Million)
Figure 66. Pharmaceutical Cold Chain Management Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Cold Chain Management market?
The top companies in the global Pharmaceutical Cold Chain Management market are Aeris Group、American Aerogel Corporation、Cold Chain Technologies.
Related Reports
Pharmaceutical Cold Chain Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 130
USD 3950.00
(Single User License)
Global Pharmaceutical Cold Chain Management Market Research Report 2026
The global Pharmaceutical Cold Chain Management market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 123
USD 2900.00
(Single User License)
Global Pharmaceutical Cold Chain Management Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Cold Chain Management market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 108
USD 4250.00
(Single User License)
Pharmaceutical Cold Chain Management- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 137
USD 3950.00
(Single User License)
Global Pharmaceutical Cold Chain Management Market Research Report 2025
The global market for Pharmaceutical Cold Chain Management was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 99
USD 2900.00
(Single User License)
Global Pharmaceutical Cold Chain Management Market Insights, Forecast to 2030
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published Date: 2024-04-08
Pages: 116
USD 4900.00
(Single User License)
Pharmaceutical Cold Chain Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published Date: 2024-02-22
Pages: 133
USD 3950.00
(Single User License)
Global Pharmaceutical Cold Chain Management Market Research Report 2024
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published Date: 2024-01-17
Pages: 96
USD 2900.00
(Single User License)
Pharmaceutical Cold Chain Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 130
USD 3950.00 (Single User License)Global Pharmaceutical Cold Chain Management Market Research Report 2026
The global Pharmaceutical Cold Chain Management market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 123
USD 2900.00 (Single User License)Global Pharmaceutical Cold Chain Management Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Cold Chain Management market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 108
USD 4250.00 (Single User License)Pharmaceutical Cold Chain Management- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 137
USD 3950.00 (Single User License)Global Pharmaceutical Cold Chain Management Market Research Report 2025
The global market for Pharmaceutical Cold Chain Management was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 99
USD 2900.00 (Single User License)Global Pharmaceutical Cold Chain Management Market Insights, Forecast to 2030
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published: 2024-04-08
Pages: 116
USD 4900.00 (Single User License)Pharmaceutical Cold Chain Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published: 2024-02-22
Pages: 133
USD 3950.00 (Single User License)Global Pharmaceutical Cold Chain Management Market Research Report 2024
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published: 2024-01-17
Pages: 96
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now